PVT1 usually interacts with c-Myc to mediate malignant tumor progression, such as proliferation, invasion, metastasis, therapeutic resistance, etc. In general, PVT1 overexpression is often associated with poor prognosis in patients, and it has been regarded as a novel carcinogenic factor [29]. This evidence concerns the gene PVT1 and cancer.